Detalhe da pesquisa
1.
Decade-long leukaemia remissions with persistence of CD4+ CAR T cells.
Nature
; 602(7897): 503-509, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35110735
2.
Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis.
N Engl J Med
; 388(25): 2338-2348, 2023 Jun 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37342922
3.
Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemia.
Haematologica
; 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38634143
4.
Chronic graft-versus-host disease. Part I: Epidemiology, pathogenesis, and clinical manifestations.
J Am Acad Dermatol
; 90(1): 1-16, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36572065
5.
Chronic graft-versus-host disease. Part II: Disease activity grading and therapeutic management.
J Am Acad Dermatol
; 90(1): 19-36, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36572064
6.
Real-world effectiveness of intensive chemotherapy with 7&3 versus venetoclax and hypomethylating agent in acute myeloid leukemia.
Am J Hematol
; 98(8): 1254-1264, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37334852
7.
Author Correction: Decade-long leukaemia remissions with persistence of CD4+ CAR T cells.
Nature
; 612(7941): E22, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36477542
8.
One versus two sets of busulfan therapeutic drug monitoring in myeloablative allogeneic hematopoietic cell transplant.
J Oncol Pharm Pract
; : 10781552231189199, 2023 Aug 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37603585
9.
Management of relapsed cutaneous T-Cell lymphoma following allogeneic hematopoietic stem cell transplantation: Review with representative patient case.
Dermatol Ther
; 35(7): e15538, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35477952
10.
Fluconazole-Induced adrenal insufficiency following allogeneic hematopoietic cell transplant.
J Oncol Pharm Pract
; 28(8): 1922-1925, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35289200
11.
Pentosan polysulfate for the treatment of hemorrhagic cystitis after allogeneic hematopoietic cell transplant.
J Oncol Pharm Pract
; 28(7): 1609-1612, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35642262
12.
Day 4 vs. day 12 G-CSF administration following reduced intensity peripheral blood allogeneic stem cell transplant.
J Oncol Pharm Pract
; 28(4): 892-897, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35191732
13.
The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases.
Blood
; 133(7): 754-762, 2019 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30545834
14.
Driving Distance and Patient-Reported Outcomes in Hematopoietic Cell Transplantation Survivors.
Biol Blood Marrow Transplant
; 26(11): 2132-2138, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32781287
15.
Risk of invasive fungal infections in patients with high-risk MDS and AML receiving hypomethylating agents.
Am J Hematol
; 95(7): 792-798, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32242967
16.
Age and gender differences in financial distress among hematopoietic cell transplant survivors.
Support Care Cancer
; 28(9): 4361-4371, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31916007
17.
Oral Vancomycin Prophylaxis Is Highly Effective in Preventing Clostridium difficile Infection in Allogeneic Hematopoietic Cell Transplant Recipients.
Clin Infect Dis
; 68(12): 2003-2009, 2019 05 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-30256954
18.
Extended CCR5 Blockade for Graft-versus-Host Disease Prophylaxis Improves Outcomes of Reduced-Intensity Unrelated Donor Hematopoietic Cell Transplantation: A Phase II Clinical Trial.
Biol Blood Marrow Transplant
; 25(3): 515-521, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30315941
19.
Comparison of High Doses of Total Body Irradiation in Myeloablative Conditioning before Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 25(12): 2398-2407, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31473319
20.
Higher Donor Apheresis Blood Volumes Are Associated with Reduced Relapse Risk and Improved Survival in Reduced-Intensity Allogeneic Transplantations with Unrelated Donors.
Biol Blood Marrow Transplant
; 24(6): 1203-1208, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29408506